40033211000001102: Bimekizumab (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Virtual therapeutic moiety\Bimekizumab

\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing antibody\Product containing monoclonal antibody\Bimekizumab

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 29-Sep 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

2007021000001110 Bimekizumab en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

2007041000001117 Bimekizumab (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Bimekizumab	Is a	Virtual therapeutic moiety	true	Inferred relationship	Existential restriction modifier
Bimekizumab	Is a	Product containing monoclonal antibody	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Bimekizumab 160mg/1ml solution for injection pre-filled syringes	Is a	True	Bimekizumab	Inferred relationship	Existential restriction modifier
Bimekizumab 160mg/1ml solution for injection pre-filled disposable devices	Is a	True	Bimekizumab	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets